Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Butalbital,Paracetamol,Caffeine
Therapeutic Area : Neurology
Study Phase : Approved
Sponsor : Senores Pharmaceuticals
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : Butalbital, Acetaminophen and Caffeine Capsules USP, 50 mg/325 mg/40 mg, a therapeutic equivalent of reference listed drug Butalbital, Acetaminophen, and Caffeine capsules of Mayne Pharma, indicated for relief of symptom complex of tension (or muscle con...
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Not Applicable
March 17, 2022
Lead Product(s) : Butalbital,Paracetamol,Caffeine
Therapeutic Area : Neurology
Highest Development Status : Approved
Sponsor : Senores Pharmaceuticals
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?